Literature DB >> 18321489

Optimizing the number of cleavage stage embryos to transfer on day 3 in women 38 years of age and older: a Society for Assisted Reproductive Technology database study.

Judy E Stern1, Marlene B Goldman, Harry Hatasaka, Todd A MacKenzie, Eric S Surrey, Catherine Racowsky.   

Abstract

OBJECTIVE: To determine the optimal number of day 3 embryos to transfer in women >or=38 years by conducting an evidence-based evaluation.
DESIGN: Retrospective analysis of 2000-2004 national SART data.
SETTING: National writing group. PATIENT(S): A total of 36,103 day 3 embryo transfers in women >or=38 years undergoing their first assisted reproductive technology cycle. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Logistic regression was used to model the probability of pregnancy, delivery, and multiple births (twin or high order) based on age- and cycle-specific parameters. RESULT(S): Pregnancy rates, delivery rates, and multiple rates increased up to transfer of three embryos in 38-year-olds and four in 39-year-olds; beyond this number, only multiple rates increased. In women >or=40 years, delivery rates and multiple rates climbed steadily with increasing numbers transferred. Multivariate analysis confirmed the statistically significant effect of age, number of oocytes retrieved, and embryo cryopreservation on delivery and multiple rates. Maximum FSH level was not an independent predictor by multivariate analysis. Use of intracytoplasmic sperm injection was associated with lowered delivery rate. CONCLUSION(S): No more than three or four embryos should be transferred in 38- and 39-year-olds, respectively, whereas up to five embryos could be transferred in >or=40-year-olds. Numbers of embryos to transfer should be adjusted according to number of oocytes retrieved and availability of excess embryos for cryopreservation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321489     DOI: 10.1016/j.fertnstert.2007.12.051

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Number of supernumerary vitrified blastocysts is positively correlated with implantation and live birth in single-blastocyst embryo transfers.

Authors:  Micah J Hill; Kevin S Richter; Ryan J Heitmann; Terrance D Lewis; Alan H DeCherney; James R Graham; Eric Widra; Michael J Levy
Journal:  Fertil Steril       Date:  2013-02-20       Impact factor: 7.329

2.  The human oviduct transcriptome reveals an anti-inflammatory, anti-angiogenic, secretory and matrix-stable environment during embryo transit.

Authors:  A P Hess; S Talbi; A E Hamilton; D M Baston-Buest; M Nyegaard; J C Irwin; F Barragan; J S Kruessel; A Germeyer; L C Giudice
Journal:  Reprod Biomed Online       Date:  2013-07-11       Impact factor: 3.828

3.  Does transferring three or more embryos make sense for a well-defined population of infertility patients undergoing IVF/ICSI?

Authors:  T Masschaele; J Gerris; F Vandekerckhove; P De Sutter
Journal:  Facts Views Vis Obgyn       Date:  2012

Review 4.  Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.

Authors:  Philippe Lehert; Efstratios M Kolibianakis; Christos A Venetis; Joan Schertz; Helen Saunders; Pablo Arriagada; Samuel Copt; Basil Tarlatzis
Journal:  Reprod Biol Endocrinol       Date:  2014-02-20       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.